HomeSLRX • NASDAQ
add
Salarius Pharmaceuticals Inc
Previous close
$0.72
Day range
$0.70 - $0.75
Year range
$0.46 - $7.20
Market cap
1.28M USD
Avg Volume
406.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.49M | 53.36% |
Net income | -1.46M | -66.02% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.49M | -53.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.43M | -58.74% |
Total assets | 3.02M | -54.10% |
Total liabilities | 1.51M | 16.32% |
Total equity | 1.51M | — |
Shares outstanding | 1.75M | — |
Price to book | 0.69 | — |
Return on assets | -108.16% | — |
Return on capital | -149.26% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.46M | -66.02% |
Cash from operations | -742.52K | 50.87% |
Cash from investing | — | — |
Cash from financing | -106.98K | 36.86% |
Net change in cash | -849.50K | 49.45% |
Free cash flow | -209.03K | 83.26% |
About
Founded
2014
Headquarters
Website
Employees
2
